Saturday, April 13, 2024
wellness India Expo
Home Tags Therapies

Tag: Therapies

Siddhanta Medicity to raise USD 108 Million in partnership with UK-based...

Collaboration for clinical research and development in the field of NK Cell and Mesenchymal Stem Cell Therapies and to Propel Healthcare in India

BioVoice eMagazine July 2023 | Issue 7 | Volume 4

This edition showcases the top 10 biotechnologies to watch out for in 2023. Insightful interviews of Piyush Sohani, Managing Director, Sistema.bio India and Dr Rachna Dave, CEO & Founder of MicroGO.

IIT Madras researchers show ways to improve efficacy of anti-cancer treatments

The Research Team is now exploring collaborations with cancer hospitals to try their ‘simple timing’ strategy to enhance the effectiveness of cancer treatment..................

COVID-19: Immune profiling for development of therapies could be a game...

With recent advances in genome sequencing and data availability, it is high time that the Indian drug majors focus on tapping the vast potential of the innovative immune profiling field for the development of novel therapies.......................

Takeda expands India portfolio of rare disease therapies

The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................

Significance of ALK gene rearrangement in ‘Non-Small Cell Lung Cancer’ cases...

As per a study by the CORE Diagnostics, the ALK gene mutations is a significant biomarker among Indian patients for targeted therapies in lung cancer and also a boost for Targeted Lung Cancer treatment by directing efforts towards more prevalent genetic biomarkers..........

The Qutub Minar turns red for World Hemophilia Day

Delhi’s iconic monument, Qutub Minar was lit up with red lights as part of the World Hemophilia Day campaign to increase awareness and understanding of this genetic disease in the society.............

Pricing adjustments for CAR-T therapies likely to take place in 2018,...

A fairly comprehensive study reported in February 2018 on the Health Affairs Blog claims that Novartis could lower the price of Kymriah by two-thirds and still achieve a profit..................

‘Cold’ glioblastoma tumors require combination therapies to improve response rates, says...

It is the most common form of grade IV brain cancer and considered to be one of the most ‘immune-cold’ tumors relative to other cancers, which limits the effectiveness of immunotherapies................

Oracle Health Sciences reimagines its clinical development technology

The launch of new cloud-based eClinical environment unifies clinical development operations and information to help life sciences companies bring therapies to market faster and more cost-effectively...........